[Gastrointestinal haemorrhage in the cirrhotic. The value of injectable posterior pituitary extract (author's transl)].
The authors report the experience which the have acquired since 1970 in the use of posterior pituitary extract as part of the treatment of gastrointestinal bleeding in cirrhotics. 100 cases have been collected, in 73 patients. These may be divided into two groups: one of 32 patients, who did not receive posterior pituitary extract, with 31 deaths, and one of 41 patients who did receive the extract, with 6 deaths. These figures should be viewed in parallel with the results obtained by other techniques, and it would seem that comparison with other statistics is feasible. In addition, emphasis must be placed upon the simplicity of the administration and surveillance of treatment. Attention is also drawn to the absence of any inherent complication associated with the use of the drug, despite the administration, in certain cases, of high doses.
D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D006801:Humans; D007267:Injections; D008103:Liver Cirrhosis / Q000150:complications*; D010121:Oxytocin / Q000008:administration & dosage; D010904:Pituitary Gland, Posterior; D014020:Tissue Extracts / Q000008:administration & dosage*; D014667:Vasopressins / Q000008:administration & dosage
D014020:Tissue Extracts; D014667:Vasopressins; D010121:Oxytocin
Hémorragies digestives du cirrhotique. Intérêt de la post-hypophyse injectable.